Cash on Hand for Illumina (ILMN)
According to Illumina's latest reported financial statements, the company's latest reported cash and short-term investments is $1.63B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
ILMN
Currently viewingRevenueSwitch metric
Latest period
$1.63B
YoY change
+33.9%
5Y CAGR
-14.0%
Peak year (2018)
$3.51B
Latest annual
$1.63B
Cash on Hand history chart for Illumina (ILMN) from 1999 to 2025
Cash on Hand history table for Illumina (ILMN) from 1999 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $1.63B | +33.9% | ||
| 2024 | $1.22B | +15.7% | ||
| 2023 | $1.05B | -48.3% | ||
| 2022 | $2.04B | +52.1% | ||
| 2021 | $1.34B | -61.4% | ||
| 2020 | $3.47B | +1.7% | ||
| 2019 | $3.41B | -2.8% | ||
| 2018 | $3.51B | +63.7% | ||
| 2017 | $2.15B | +37.6% | ||
| 2016 | $1.56B | +12.4% | ||
| 2015 | $1.39B | +3.6% | ||
| 2014 | $1.34B | +14.8% | ||
| 2013 | $1.17B | -13.7% | ||
| 2012 | $1.35B | +13.5% | ||
| 2011 | $1.19B | +33.0% | ||
| 2010 | $894.29M | +28.9% | ||
| 2009 | $693.53M | +8.4% | ||
| 2008 | $640.08M | +65.8% | ||
| 2007 | $386.08M | +195.2% | ||
| 2006 | $130.80M | +157.4% | ||
| 2005 | $50.82M | -7.2% | ||
| 2004 | $54.79M | +67.1% | ||
| 2003 | $32.78M | -39.0% | ||
| 2002 | $53.76M | -40.6% | ||
| 2001 | $90.49M | -22.7% | ||
| 2000 | $117.10M | +253.9% | ||
| 1999 | $33.09M | — |
Cash on Hand values are taken from Illumina's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual cash and short-term investments for Illumina (ILMN) came in at $1.63B – surged 33.9% year-over-year.
Illumina cash and short-term investments compound annual growth for the 2020–2025 (5 years) window is -14.0%, sustaining 2 straight years of year-over-year growth.
Between 2018 and 2025, Illumina cash and short-term investments plunged 53.5%, falling from $3.51B to $1.63B.
2018 marks the peak cash and short-term investments at $3.51B, with the historical low of $32.78M recorded in 2003.
Illumina (ILMN) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $11.85B.
Illumina Cash on Hand by Year
Illumina Cash on Hand 2025: $1.63B
Illumina cash and short-term investments in 2025 was $1.63B, surged 33.9% from 2024.
Illumina Cash on Hand 2024: $1.22B
Illumina cash and short-term investments in 2024 was $1.22B, grew 15.7% from 2023.
Illumina Cash on Hand 2023: $1.05B
Illumina cash and short-term investments in 2023 was $1.05B, plunged 48.3% below 2022.
Illumina Cash on Hand 2022: $2.04B
Illumina cash and short-term investments in 2022 was $2.04B, surged 52.1% from 2021.
Illumina Cash on Hand 2021: $1.34B
Illumina cash and short-term investments in 2021 was $1.34B.
See more financial history for Illumina (ILMN).
Sector peers — Cash on Hand
Companies in the same sector as Illumina, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Illumina's cash and short-term investments?
- Latest reported cash and short-term investments for Illumina (ILMN) is $1.63B (period ending December 28, 2025).
How has Illumina cash and short-term investments changed year-over-year?
- Illumina (ILMN) cash and short-term investments changed +33.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Illumina cash and short-term investments?
- Illumina (ILMN) cash and short-term investments compound annual growth rate is -14.0% over the most recent 5 years available.
When did Illumina cash and short-term investments hit its highest annual value?
- Illumina cash and short-term investments reached its highest annual value of $3.51B in 2018.
What was Illumina cash and short-term investments in 2024?
- Illumina (ILMN) cash and short-term investments in 2024 was $1.22B.
What was Illumina cash and short-term investments in 2025?
- Illumina (ILMN) cash and short-term investments in 2025 was $1.63B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ILMN Overview
Company profile, financial tools, and key metrics
ILMN Revenue Counter
Earns $137.68 every second. See per minute, hour, and day.
ILMN Earnings Counter
Earns $26.95 per second net profit. See per minute, hour, and day.
ILMN Economic Scale
Exceeds Aruba's GDP. Compare with world economies.
ILMN What If Invested
What if you had invested $1,000? See historical returns from any date.
ILMN How It Makes Money
Discover visual breakdown of $4.34B in revenue — where it comes from and where it goes.
ILMN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ILMN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ILMN Daily Price Character
Explosive · 50.0% historical win rate (green days). Streaks & record days.
ILMN Buybacks
3.61% TTM buyback yield. Shareholder yield & SBC comparison.
ILMN Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.